Candel Therapeutics (CADL) Asset Writedowns and Impairment (2023)
Historic Asset Writedowns and Impairment for Candel Therapeutics (CADL) over the last 1 years, with Q4 2023 value amounting to $228000.0.
Historic Asset Writedowns and Impairment for Candel Therapeutics (CADL) over the last 1 years, with Q4 2023 value amounting to $228000.0.